{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T11:47:25.384899+00:00","company":{"ticker":"GNLX","cik":1231457,"company_name":"GENELUX Corp"},"pagination":{"limit":100,"returned":4,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"material_agreement","fact_key":"b239cac01ac4eaa7b5a1b2b6a02f31d87027cac5","cik":1231457,"ticker":"GNLX","company_name":"GENELUX Corp","filed_at":"2026-03-19T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Sales Agreement","agreement_type":"atm_program","counterparty":"TD Securities (USA) LLC","effective_date":"2026-03-19","item_codes_triggered":["1.01"],"value_text":"up to $100,000,000"},"claim":"GENELUX Corp entered into Sales Agreement with TD Securities (USA) LLC valued at up to $100,000,000 (effective 2026-03-19).","evidence_excerpt":"On March 19, 2026, Genelux Corporation (the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with TD Securities (USA) LLC (“TD Cowen”), pursuant to which the Company may, from time to time, offer and sell shares of the Company’s common stock, par value $0.001 per share (the “Placement Shares”), having an aggregate offering price of up to $100,000,000, through TD Cowen, acting as the Company’s sales agent and/or principal.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001493152-26-011649","anchor_url":"https://secwatch.observer/filing/0001493152-26-011649#claim-b239cac01ac4eaa7b5a1b2b6a02f31d87027cac5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315226011649/0001493152-26-011649-index.htm"},{"fact_type":"executive_change","fact_key":"9eac72b8fd","cik":1231457,"ticker":"GNLX","company_name":"GENELUX Corp","filed_at":"2025-02-03T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2025-01-30","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Matt Pulisic was appointed as Chief Financial Officer at GENELUX Corp.","evidence_excerpt":"On February 3, 2025, the Company announced the appointment of Matt Pulisic as the Company’s Chief Financial Officer, effective as of January 30, 2025 (the “ Effective Date ”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-004554","anchor_url":"https://secwatch.observer/filing/0001493152-25-004554#claim-9eac72b8fd","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/0001493152-25-004554-index.htm"},{"fact_type":"executive_change","fact_key":"daab59e0a8","cik":1231457,"ticker":"GNLX","company_name":"GENELUX Corp","filed_at":"2025-02-03T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2025-01-29","interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":"Matt Pulisic","successor_named":true},"claim":"Lourie Zak resigned as Chief Financial Officer at GENELUX Corp.","evidence_excerpt":"On January 29, 2025 (the “ Separation Date ”), Lourie Zak resigned as Chief Financial Officer of Genelux Corporation (the “ Company ”), effective immediately.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001493152-25-004554","anchor_url":"https://secwatch.observer/filing/0001493152-25-004554#claim-daab59e0a8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/0001493152-25-004554-index.htm"},{"fact_type":"executive_change","fact_key":"0a45d29273","cik":1231457,"ticker":"GNLX","company_name":"GENELUX Corp","filed_at":"2024-10-03T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-10-18","interim":false,"role":"Vice President, Head of Quality","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Caroline Jewett resigned as Vice President, Head of Quality at GENELUX Corp.","evidence_excerpt":"On September 23, 2024, Caroline Jewett notified Genelux Corporation (the “Company”) of her resignation as Vice President, Head of Quality of the Company, effective as of October 18, 2024.","confidence":1.0,"filing_url":"https://secwatch.observer/filing/0001493152-24-039417","anchor_url":"https://secwatch.observer/filing/0001493152-24-039417#claim-0a45d29273","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315224039417/0001493152-24-039417-index.htm"}]}